Detalhe da pesquisa
1.
Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.
J Clin Med
; 9(12)2020 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33255857
2.
Further psychometric validation of the GAH scale: Responsiveness and effect size.
J Geriatr Oncol
; 8(3): 211-215, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017687